This page has been fact checked by an experienced mesothelioma Patient Advocate. Sources of information are listed at the bottom of the article.
We make every attempt to keep our information accurate and up-to-date.
Please Contact Us with any questions or comments.
Dr. Peter G. Shields is a medical oncologist and researcher at The Ohio State University Comprehensive Cancer Center and the James Cancer Hospital. He is a tenured professor in the Department of Internal Medicine at The Ohio State University College of Medicine and in the Division of Epidemiology at The Ohio State University College of Public Health.
Dr. Shields’ clinical expertise is in the treatment of lung cancers, thoracic malignancies including malignant pleural mesothelioma, and small cell and non-small-cell lung carcinoma.
Education and Career
Dr. Shields earned a bachelor of arts degree in Biochemistry and American Civilization at the University of Pennsylvania. After graduating Magna Cum Laude from Penn, he went on to earn his medical degree at the Icahn School of Medicine at Mount Sinai and completed a residency in Internal Medicine at George Washington University. He followed his residency with a fellowship in Hematology and Medical Oncology there and then completed a Post-Doctoral Fellowship at the National Cancer Institute National Institutes of Health Clinical Center.
After completing his education, Dr. Shields practiced and researched for several years at Georgetown University where he was a tenured professor in the Departments of Oncology and Medicine and Deputy Director of the Lombardi Comprehensive Cancer Center at Georgetown University. He held various titles at Georgetown, including Interim-Chair of the Department of Medicine, Vice-Chair of the Department of Oncology, Associate Director for Cancer Control and Population Sciences, and Program Leader for Cancer Genetics and Epidemiology in the Cancer Center. He also directed an NCI-funded joint partnership for cancer prevention and control for health disparities with the University of District of Columbia and had a long history of working in the DC community, including serving as President of the Board of Directors for a free medical clinic there and serving on the D.C. Board of Medicine.
In his current role as deputy director of the OSUCCC – James, he oversees the scientific research programs and research infrastructure from 11 of Ohio State’s 15 colleges.
Dr. Shields is a dedicated researcher. He holds the Julius F. Stone Chair in Cancer Research and is a fellow in the American College of Epidemiology. He has published more than 210 studies in high-profile journals on topics ranging from toxicology and epidemiology to behavior and health disparities, and has served or is serving on editorial boards of journals including Carcinogenesis; Molecular Carcinogenesis; Journal of Cancer Epidemiology; and Cancer, Epidemiology, Biomarkers and Prevention.
His research focus is on cancer prevention and the causes of cancer, with a focus on developing tests to identify those who are at the greatest risk for diagnosis. A significant percentage of his focus is on tobacco products, but he has also spent significant time leading a Department of Defense Breast Cancer Center of Excellence to explore the relationship between alcohol and breast cancer.
Dr. Shields is currently the principal investigator for two clinical trials in progress at The Ohio State University. These are:
- Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
- Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs
Written by Terri Oppenheimer
Terri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Page Edited by Patient Advocate Dave Foster
Dave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.